Bruker Corporation (BRKR)
Bruker (BRKR) Rolls Out the First 1.2 GHz NMR System in Asia
Bruker (BRKR) installs the 1.2 GHz Avance NMR Spectrometer at KBSI, enabling advanced scientific discoveries.
Bruker (BRKR) Reliance on International Sales: What Investors Need to Know
Evaluate Bruker's (BRKR) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Bruker Corporation (BRKR) Q2 2024 Earnings Call Transcript
Bruker Corporation (NASDAQ:BRKR ) Q2 2024 Earnings Conference Call August 6, 2024 8:30 AM ET Company Participants Joe Kostka - Associate Director, Investor Relations Frank Laukien - President and CEO Gerald Herman - Executive Vice President and CFO Conference Call Participants Puneet Souda - Leerink Partners Patrick Donnelly - Citi Rachel Vatnsdal - JPMorgan Tycho Peterson - Jefferies Doug Schenkel - Wolfe Research Josh Waldman - Cleveland Research Operator Good day. And welcome to the Bruker Corporation Second Quarter 2024 Earnings Call.
Bruker (BRKR) Partners With NovAliX to Boost Drug Discovery
Bruker (BRKR) invests in NovAliX to accelerate advancements in drug discovery, combining cutting-edge biophysical methods and technologies to develop new treatments and enhance biopharma solutions.
Bruker (BRKR) Q2 Earnings Meet Mark, '24 Revenue Outlook Raised
Bruker (BRKR) delivers robust revenue growth in the second quarter despite soft general market conditions.
Compared to Estimates, Bruker (BRKR) Q2 Earnings: A Look at Key Metrics
The headline numbers for Bruker (BRKR) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Is the Options Market Predicting a Spike in Bruker (BRKR) Stock?
Investors need to pay close attention to Bruker (BRKR) stock based on the movements in the options market lately.
Bruker (BRKR) Q2 Earnings Meet Estimates
Bruker (BRKR) came out with quarterly earnings of $0.52 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.50 per share a year ago.
Zacks Industry Outlook Mettler-Toledo and Bruker
Mettler-Toledo and Bruker have been highlighted in this Industry Outlook article.
2 Instruments Stocks to Watch From a Prospering Industry
The Zacks Instruments - Scientific industry participants like MTD and BRKR are gaining from strong life science, pharmaceutical and academic end-market demand despite the challenging macroeconomic environment.
Bruker (BRKR) Earnings Expected to Grow: What to Know Ahead of Q2 Release
Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Bruker (BRKR) Beat Estimates Again in Its Next Earnings Report?
Bruker (BRKR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
